DOG Deutsche Ophthalmologische Gesellschaft 105. DOG-Kongress
  English Site  
  DOG Congress Home

Invitation
Organization, Deadlines
Overview of the Congress

Scientific Programme
Opening Ceremony
Ceremony 150 Years of DOG
Thursday, 20.September
Friday, 21.September
Saturday, 22.September
Sunday, 23.September
Poster Sessions
Symposia
Courses
Satellite Programme

Information
Social Programme
Sponsors, Exhibitors

DOG Homepage
 

Abstract

SO.06.04

Results after collagen cross linking with riboflavin and ultraviolet A radiation for keratoconus

Kampik D., Kampik K., Heß M., Geerling G.
University Eye Hospital, Wuerzburg

Objective: Photochemical collagen crosslinking with riboflavin and UV-A radiation is reported to strengthen the cornea in keratoconus. In our study we report the postoperative follow-up after crosslinking regarding progression of keratectasia, visual acuity, safety and side effects.
Methods: 38 patients with progressive keratoconus confirmed by topography and patient history received crosslinking treatment. Following corneal abrasion, riboflavin 0,1% solution was applied over 30 minutes and the cornea exposed to UV-A (365 nm) for further 30 minutes (total surface dose 5,4 J/cm2). Follow-up ranged between 3 and 15 months.
Results: All patients showed initial haze (maximum 2+) and increase of epithelial surface irregularity resulting in a temporary loss of vision, but this resolved within 2 months. Even in patients with atopic dermatitis epithelial healing was not delayed. Maximum K readings decreased from 51.4 to 50.3 dpt. The maximum radius of curvature in the keratoconus apex increased by 4,5 dpt for 4-8 weeks postoperatively followed by a decrease below the preoperative value (preop 51,3 dpt vs. postop 50,3 dpt). Visual acuity improved by 1 line on average. Central pachymetry and endothelial cell count remained unchanged.
Conclusions: Collagen cross linking showed no long term complications. Despite transitory visual loss for 4-6 weeks a return or slight increase of visual acuity can be expected. No case showed a progression of keratoconus during this study. A longer follow-up time and a randomized controlled study are crucial for further assessment of this method to establish whether it is capable of preventing progression of keratoconus.

 
Previous page    
Top of page